Industry says failure to consider new ways of assessing the value of drugs, including outcomes-based approaches and the use of real world evidence, represents a missed opportunity to promote sustainability of Europe’s healthcare systems
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.